← back to search

Daanish Hoda

LDS Hospital · US
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Neutropenia and Cancer Infections, and Chronic Lymphocytic Leukemia Research.
h-index
16
citations
1,378
works
75
NIH funding
primary concept
Medicine
email

Recent publications

Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study
Blood Advances 2025cited by 9position: middledoi
Lisocabtagene Maraleucel as Second-Line Therapy for R/R Large B-Cell Lymphoma in Patients Not Intended for Hematopoietic Stem Cell Transplant: Final Analysis of the Phase 2 PILOT Study
Blood 2023cited by 15position: middledoi
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19
CHEST Journal 2022cited by 30position: middledoi
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study
The Lancet Rheumatology 2020cited by 308position: middledoi
Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes
Biology of Blood and Marrow Transplantation 2016cited by 55position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rebecca Champion · Norton Healthcare2 papers (2023–2025)Peter A. Riedell · Janssen (United States)2 papers (2023–2025)Scott R. Solomon · Leukemia Research Foundation2 papers (2023–2025)Edward Licitra · CancerCare2 papers (2023–2025)Leo I. Gordon · Northwestern University2 papers (2023–2025)Mehdi Hamadani · Medical College of Wisconsin2 papers (2023–2025)Neel K. Gupta · Stanford University2 papers (2023–2025)Nina D. Wagner‐Johnston · Washington University in St. Louis2 papers (2023–2025)Gerhard Hildebrandt · University of Kentucky2 papers (2023–2025)Jerill Thorpe · Bristol-Myers Squibb (United States)2 papers (2023–2025)James Essell · Oncology Hematology Care2 papers (2023–2025)Alison R. Sehgal · UPMC Hillman Cancer Center2 papers (2023–2025)John E. Godwin · University of Western States2 papers (2023–2025)K. OGASAWARA · Bristol-Myers Squibb (United States)2 papers (2023–2025)Brandon Webb · Stanford Medicine2 papers (2016–2020)Nilanjan Ghosh · Wake Forest Baptist Comprehensive Cancer Center2 papers (2023–2025)Patrick M. Reagan · Outcomes Research Consortium2 papers (2023–2025)Victor A. Chow · Seattle University2 papers (2023–2025)Rajneesh Nath · Banner Health2 papers (2023–2025)Suzanne Fanning · Prisma Health2 papers (2023–2025)